David Liu
Professor and Director , Broad Institute
6th International Conference on CRISPR Technologies
October 17, 2023 to October 19, 2023
The 2023 International Conference on CRISPR Technologies will focus on the latest advances in the genome editing field, bringing together key stakeholders with aligned interests across the spheres of academia and industry. The program will feature talks across many facets of this field, including the optimization of safe and effective DNA, RNA, and epigenetic editing technologies; the continued discovery and optimization of naturally-occurring CRISPR and non-CRISPR enzymes; the development of precision technologies capable of generating nucleotide- or kilobase-scale edits; and overcoming barriers to realizing the full potential of each of these tools.
Abstract Submission Deadline: August 31, 2023
Early Bird Deadline: September 5, 2023
Sponsors
Our field is very fast-paced and dynamic, so I’m really looking forward to this conference. Talks will highlight the leading edge of CRISPR technologies and also key challenges that lie ahead.
Featured Speakers
-
-
Sekar Kathiresan
CEO, Verve Therapeutics -
Fyodor Urnov
Professor, Molecular and Cell Biology Department, Scientific Director of Technology and Translation , Innovative Genomics Institute (IGI) -
Prashant Mali
Professor, Department of Bioengineering, University of California San Diego -
Erik Sontheimer
Pillar Chair in Biomedical Research and Professor, University of Massachusetts Chan Medical School -
Gerald Schwank
Assistant Professor, ETH Zurich -
Mandana Arbab
Assistant Professor, Harvard Medical School -
Ailong Ke
Professor of Biochemistry and Structural Biology, Cornell University -
Richard Sherwood
Assistant Professor of Medicine , Brigham and Women’s Hospital and Harvard Medical School -
Teresa Davoli
Assistant Professor, New York University -
Ahmad (Mo) Khalil
Associate Professor, Boston University -
Omar Abudayyeh
Principal Investigator , McGovern Institute Fellow, MIT -
Jonathan Gootenberg
Principal Investigator , McGovern Institute Fellow, MIT -
Matthew Stanton
CSO , Generation Bio -
Luca Pinello
Associate Pathologist , Massachusetts General Hospital (MGH) -
Cicera Lazzarotto
Senior Scientist , Beam Therapeutics -
Samagya Banskota
Assistant Professor , Boston University -
Kiran Musunuru
Professor , Perelman School of Medicine at the University of Pennsylvania -
Sergey Shmakov
Research Fellow , NIH -
Max Wilkinson
Postdoctoral Fellow, Broad Institute -
Soumya Kannan
Postdoctoral Fellow, Broad Institute -
Matt Walker
Ph.D Student , Columbia University -
Hamideh Parhiz
Research Assistant Professor, Perelman School of Medicine at the University of Pennsylvania -
Jung-Un Park
Postdoctoral Research Associate , St. Jude Children’s Research Hospital -
Paul Blainey
Associate Professor , Broad Institute -
Jonathan Phillips
Vice President of Pharmacology & Toxicology, Intellia Therapeutics -
Nicole Gaudelli
Vice President of Gene Editing, Beam Therapeutics -
Ben Deverman
Senior Director of Vector Engineering and an Institute Scientist, Broad Institute of MIT and Harvard -
Venkat Krishnamurthy
Senior Vice President and Head of Platform , Korro Bio -
Andrew Young
Director , Sangamo Therapeutics -
Charles Albright
CSO, Affinia Therapeutics
Top Reasons to Present
- Interactions amongst the diversity of attendees will accelerate progress in the field by expediting the translation of basic science discoveries into applications.
- Share knowledge and connect with scientists working in the area of CRISPR technologies.
- Benefit from creative input from colleagues working in allied fields.
- Gain exposure to an attentive, well-informed audience at each talk.
- Identify colleagues who might use your research in a collaboration.
- Identify trends that might influence your current research.
- Increase your international visibility.
Session Topics
This conference will bring together global experts in both the fundamental understanding of current and next generation CRISPR editing technologies and the translational tools necessary to apply these technologies to therapeutic opportunities. It’s a “can’t miss” conference if you’re working in this space.
Top Reasons to Attend
- Learn about the latest applications of technologies including functional genomics, scalable biological perturbations, and preclinical studies, with updates on clinical progress toward new classes of genetic treatments for diseases.
- Look forward to updates on multiple CRISPR subfields, and learn about the challenges that remain for unlocking the full potential of CRISPR technologies.
- Meet experts and leaders in the CRISPR field.
- Obtain a broad view of the recent applications and developments in CRISPR technologies, and gain insight into where trends in the field are heading.
- Develop new collaborations and build relationships for current and future projects.
- Enjoy a slate of exceptional guest speakers presenting the state-of-the-art in CRISPR technologies and beyond .
This conference will bring together some of the most innovative scientists in genome engineering, and will present today's greatest triumphs — and challenges — in harnessing CRISPR for transformative technologies and medicines.
Who Should Attend
- Scientists at all career stages
- Cell biologists in academia and industry at all levels
- Scientists in industry and academia
- Students and senior researchers
- Industry decision makers/ tech scouts looking to speed up research and foster new applications
Did you know?
Sponsorship allows you to demonstrate your impact to this high-level audience and the larger CRISPR community. As a sponsor or exhibitor, you will share your technical expertise and educate attendees on how your products and services can help overcome challenges in this field, in addition to showing your commitment toward supporting a conference that will benefit advances in research.